Investors

Press Releases

Propanc Commences GLP-Compliant 28-Day Repeat-Dose Toxicity Study

Dec 22, 2016

Propanc Health Group Presentation Now Available for On-Demand Viewing

Dec 5, 2016

Propanc Health Group Corporation to Webcast, Live, at VirtualInvestorConferences.com December 1

Nov 22, 2016

Propanc Files Application for Orphan Medicinal Product Designation in the EU for Ovarian Cancer

Nov 1, 2016

Propanc Completes Pivotal 28 Day Toxicokinetic Study for Lead Product PRP

Oct 25, 2016

Propanc Health Group Corporation Presentation Now Available for On-Demand Viewing

Sep 14, 2016

Propanc Files Application for Orphan Medicinal Product Designation in the EU for Pancreatic Cancer

Sep 7, 2016

Propanc Health Group Corporation to Webcast, Live, at VirtualInvestorConferences.com September 8

Sep 1, 2016

Propanc Retains KCSA Strategic Communications as Investor Relations and Public Relations Counsel

Aug 25, 2016

Propanc Enters Into Contract Manufacturing Agreement With AmatsiQBiologicals

Aug 23, 2016

« Previous
1
2
3
4
5
6
7
8
Next »